TLR4/NF-κB-Mediated Anti-Inflammatory and Cognitive Protective Actions of Curcuma longa and Ar-turmerone in Alzheimer’s Disease Models
Journal of Microbiology and Biotechnology · 17.09.2025 · 35
DOI: 10.4014/jmb.2506.06044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, online erschienen am 17.09.2025. Verfasst von Kyo-Nyeo Oh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jeonnam Bio Foundation, Green Bio Headquarters, Natural Resources Laboratory, Jangheung-gun, Jeollanamdo 59338, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Curcuma, Toll-Like Receptor 4, NF-kappa B. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea.
Themen: Demenz
Abstract (Originalsprache)
In our previous study, we systematically compared various extraction methods and identified the 80% ethanolic extract of Curcuma longa L. (CL-80) as the most effective in protecting neurons from stress-induced damage in both in vitro and in vivo models. Although curcumin, a major constituent of C. longa, has demonstrated neuroprotective effects, the role of ar-turmerone, a bioactive sesquiterpenoid also derived from C. longa, remains underexplored in Alzheimer's disease (AD) models. In this study, we evaluated the anti-inflammatory and cognitive-protective effects of CL-80 and ar-turmerone in both in vitro and in vivo models of amyloid-β (Aβ)-induced neurotoxicity. Primary cultured rat hippocampal neurons exposed to Aβ25-35 showed significantly increased expression of TNF-α, IFN-β, and iNOS, all of which were dose-dependently attenuated by CL-80 or ar-turmerone. Furthermore, both compounds suppressed Aβ-induced activation of the TLR4/NF-κB signaling axis at mRNA and protein levels. In an Aβ1-42-injected mouse model, oral administration of CL-80 or ar-turmerone significantly improved learning and memory performance in the Morris water maze and passive avoidance tests. Biochemical analyses of hippocampal tissues revealed reduced TLR4 expression and NF-κB activation, decreased acetylcholinesterase (AChE) activity, and restoration of acetylcholine (ACh) levels following treatment. Collectively, these findings suggest that both CL-80 and ar-turmerone exert neuroprotective effects by inhibiting TLR4/NF-κB-mediated neuroinflammation and preserving cholinergic function in an AD animal model. This study offers novel insight into the therapeutic potential of C. longa constituents for the treatment of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jeonnam Bio Foundation, Green Bio Headquarters, Natural Resources Laboratory, Jangheung-gun, Jeollanamdo 59338, Republic of Korea.
- Central R&D Center, B&Tech Co., Ltd., Naju 58205, Republic of Korea.
- Research Institute of Pharmaceutical Sciences, College of Pharmacy, Chonnam National University, Gwangju 61186, Republic of Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
Zitieren
APA
Oh, K. N., Bae, D., Oh, D. R., Hong, J. A., Kim, Y., Kim, E., Son, S. A., Lee, K. Y., & Kim, S. (2025). TLR4/NF-κB-Mediated Anti-Inflammatory and Cognitive Protective Actions of Curcuma longa and Ar-turmerone in Alzheimer’s Disease Models. Journal of Microbiology and Biotechnology, 35. https://doi.org/10.4014/jmb.2506.06044
Vancouver
Oh KN, Bae D, Oh DR, Hong JA, Kim Y, Kim E, et al. TLR4/NF-κB-Mediated Anti-Inflammatory and Cognitive Protective Actions of Curcuma longa and Ar-turmerone in Alzheimer’s Disease Models. Journal of Microbiology and Biotechnology. 2025;35. doi:10.4014/jmb.2506.06044
BibTeX
@article{Oh2025,
author = {Oh, Kyo-Nyeo and Bae, Donghyuck and Oh, Dool-Ri and Hong, Ji-Ae and Kim, Yujin and Kim, Eun and Son, Seon Ah and Lee, Kwang Youl and Kim, Sunoh},
title = {TLR4/NF-κB-Mediated Anti-Inflammatory and Cognitive Protective Actions of Curcuma longa and Ar-turmerone in Alzheimer’s Disease Models},
journal = {Journal of Microbiology and Biotechnology},
year = {2025},
volume = {35},
doi = {10.4014/jmb.2506.06044}
}
EUVIMED